NORTHERN TRUST CORP - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 48 filers reported holding ENTRADA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,239,964
+10.3%
205,061
+5.7%
0.00%0.0%
Q2 2023$2,938,583
+506.9%
194,094
+481.2%
0.00%
Q1 2023$484,199
+4.2%
33,393
-2.8%
0.00%
Q4 2022$464,547
-1.8%
34,360
+14.5%
0.00%
Q3 2022$473,000
+137.7%
29,997
+83.7%
0.00%
Q2 2022$199,000
-76.5%
16,328
-81.9%
0.00%
Q1 2022$847,000
-37.8%
90,258
+13.6%
0.00%
Q4 2021$1,361,00079,4830.00%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,425,784$69,750,00026.57%
5AM Venture Management, LLC 4,408,379$69,476,00013.31%
72 Investment Holdings, LLC 509,023$8,022,0006.36%
TCG Crossover Management, LLC 642,189$10,121,0003.04%
StepStone Group LP 761,277$11,998,0001.71%
Nan Fung Group Holdings Ltd 141,593$2,232,0001.42%
Redmile Group, LLC 1,954,419$30,802,0001.20%
Baker Brothers Advisors 4,865,819$76,685,0000.50%
MOORE CAPITAL MANAGEMENT, LP 105,000$1,655,0000.04%
Laurion Capital Management LP 199,066$3,137,0000.02%
View complete list of ENTRADA THERAPEUTICS INC shareholders